Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
BMC Infectious Diseases
Published in: BMC Infectious Diseases 1/2020

Open Access 01-12-2020 | Termination of Pregnancy | Research article

Hygiene promotion might be better than serological screening to deal with Cytomegalovirus infection during pregnancy: a methodological appraisal and decision analysis

Authors: Agathe Billette de Villemeur, Pierre Tattevin, Louis-Rachid Salmi, the French Haut Conseil de la santé publique Working Group

Published in: BMC Infectious Diseases | Issue 1/2020

Login to get access

Abstract

Background

Cytomegalovirus infection is the most frequent viral congenital infection, with possible consequences such as deafness, or psychomotor retardation. In 2016, the French High Council of Public Health was mandated to update recommendations regarding prevention of cytomegalovirus infection in pregnant women. We summarize a critical appraisal of knowledge and deterministic decision analysis comparing the current no-screening situation to serological screening during pregnancy, and to hygiene promotion.

Methods

Screening was defined as systematic serological testing, during the first trimester, with repeated tests as needed, to all pregnant women. Outcomes were: 1) severe sequela: intellectual deficiency with IQ ≤ 50 or hearing impairment < 70 dB or sight impairment (≤ 3/10 at best eye); 2) moderate sequela: any level of intellectual, hearing or sight deficiency; and 3) death or termination of pregnancy. We simulated the one-year course of cytomegalovirus infection in a cohort of 800,000 pregnant women. We developed a deterministic decision model, using best and min-max estimates, extracted from systematic reviews or original studies.

Results

Relevant data were scarce or imprecise. We estimated that 4352 maternal primary infections would result in 1741 foetal infections, and an unknown number of maternal reinfections would result in 1699 foetal infections. There would be 788 cytomegalovirus-related consequences, including 316 foetal deaths or terminations of pregnancy, and 424 moderate and 48 severe sequelae. Screening would result in a 1.66-fold increase of poor outcomes, mostly related to a 2.93-fold increase in deaths and terminations of pregnancy, not compensated by the decrease in severe symptomatic newborns. The promotion of hygiene would result in a 0.75-fold decrease of poor outcomes, related to both a decrease in severe sequelae among symptomatic newborns (RR = 0.75; min-max: 1.00–0.68), and in deaths and terminations of pregnancy (RR = 0.75; min-max: 0.97–0.68).

Conclusions

Prevention of cytomegalovirus infection during pregnancy should promote hygiene; serological screening should not be recommended.
Literature
1.
Lanzieri TM, Dollard SC, Bialek SR, Grosse SD. Systematic review of the birth prevalence of congenital cytomegalovirus infection in developing countries. Int J Infect Dis. 2014;22:44–8.PubMedPubMedCentralCrossRef
2.
Kenneson A, Cannon MJ. Review and meta-analysis of the epidemiology of congenital cytomegalovirus (CMV) infection. Rev Med Virol. 2007;17(4):253–76.PubMedCrossRef
3.
Cohen BE, Durstenfeld A, Roehm PC. Viral causes of hearing loss: a review for hearing health professionals. Trends Hear. 2014;18:2331216514541361.
4.
Dollard SC, Grosse SD, Ross DS. New estimates of the prevalence of neurological and sensory sequelae and mortality associated with congenital cytomegalovirus infection. Rev Med Virol. 2007;17(5):355–63.PubMedCrossRef
5.
6.
Rawlinson WD, Boppana SB, Fowler KB, Kimberlin DW, Lazzarotto T, Alain S, et al. Congenital cytomegalovirus infection in pregnancy and the neonate: consensus recommendations for prevention, diagnosis, and therapy. Lancet Infect Dis. 2017;17(6):e177–e88.PubMedCrossRef
7.
Cannon MJ, Griffiths PD, Aston V, Rawlinson WD. Universal newborn screening for congenital CMV infection: what is the evidence of potential benefit? Rev Med Virol. 2014;24(5):291–307.PubMedPubMedCentralCrossRef
8.
Delobel-Ayoub M, Klapouszczak D, Cans C, Arnaud C, van Bakel ME. Données épidémiologiques sur les surdités bilatérales sévères et profondes en France pour les générations 1997 à 2005. Bulletin Epidémiologique Hebdomadaire. 2015;2015(42–43):781–8.
9.
Fowler KB, McCollister FP, Sabo DL, Shoup AG, Owen KE, Woodruff JL, et al. A Targeted Approach for Congenital Cytomegalovirus Screening Within Newborn Hearing Screening. Pediatrics. 2017;139(2:e20162128.
10.
Goderis J, De Leenheer E, Smets K, Van Hoecke H, Keymeulen A, Dhooge I. Hearing loss and congenital CMV infection: a systematic review. Pediatrics. 2014;134(5):972–82.PubMedCrossRef
11.
Lanari M, Lazzarotto T, Venturi V, Papa I, Gabrielli L, Guerra B, et al. Neonatal cytomegalovirus blood load and risk of sequelae in symptomatic and asymptomatic congenitally infected newborns. Pediatrics. 2006;117(1):e76–83.PubMedCrossRef
12.
Bartlett AW, McMullan B, Rawlinson WD, Palasanthiran P. Hearing and neurodevelopmental outcomes for children with asymptomatic congenital cytomegalovirus infection: a systematic review. Rev Med Virol. 2017. https://​doi.​org/​10.​1002/​rmv.​1938. Online ahead of print. on PubMed.
13.
Newborn screening: toward a uniform screening panel and system--executive summary. Pediatrics. 2006;117(5 Pt 2):S296–307.
14.
Itell HL, Nelson CS, Martinez DR, Permar SR. Maternal immune correlates of protection against placental transmission of cytomegalovirus. Placenta. 2017;60(Suppl 1):S73–s9.PubMedPubMedCentralCrossRef
15.
Khalil A, Jones C, Ville Y. Congenital cytomegalovirus infection: management update. Curr Opin Infect Dis. 2017;30(3):274–80.PubMedCrossRef
16.
Leruez-Ville M, Ville Y. Fetal cytomegalovirus infection. Best Pract Res Clin Obstet Gynaecol. 2017;38:97–107.PubMedCrossRef
17.
Reichman O, Miskin I, Sharoni L, Eldar-Geva T, Goldberg D, Tsafrir A, et al. Preconception screening for cytomegalovirus: an effective preventive approach. Biomed Res Int. 2014;2014:135416.PubMedPubMedCentralCrossRef
18.
Adler SP. Screening for cytomegalovirus during pregnancy. Infect Dis Obstet Gynecol. 2011;2011:1–9.PubMedCrossRef
19.
Buxmann H, Hamprecht K, Meyer-Wittkopf M, Friese K. Primary human Cytomegalovirus (HCMV) infection in pregnancy. Deutsches Arzteblatt international. 2017;114(4):45–52.PubMedPubMedCentral
20.
Carrara J, N'Diaye DS, Azria E, Launay O, Rozenberg F, Yazpandanah Y, et al. Management of Cytomegalovirus Seroconversion during pregnancy in France. Fetal Diagn Ther. 2016;39(1):4–12.PubMedCrossRef
21.
Gruppo multidisciplinare "Malattie infettive in ostetricia-ginecologia e neonatologia". Percorsi diagnostico-assistenziali in Ostetricia-Ginecologia e Neonatologia - Citomegalovirus. Milano: Società Italiana di Neonatologia; 2012.
22.
Gyselaers W, Jonckheer P, Ahmadzai N, Ansari MT, Carville S, Dworzynski K, et al. What are the recommended clinical assessment and screening tests during pregnancy? Bruxelles: Belgian Health Care Knowledge Centre; 2015. p. 125.
23.
Lazzarotto T, Guerra B, Gabrielli L, Lanari M, Landini MP. Update on the prevention, diagnosis and management of cytomegalovirus infection during pregnancy. Clin Microbiol Infect. 2011;17(9):1285–93.PubMedCrossRef
24.
Rahav G. Congenital cytomegalovirus infection--a question of screening. Isr Med Assoc J. 2007;9(5):392–4.PubMed
25.
Revello MG, Fabbri E, Furione M, Zavattoni M, Lilleri D, Tassis B, et al. Role of prenatal diagnosis and counseling in the management of 735 pregnancies complicated by primary human cytomegalovirus infection: a 20-year experience. J Clin Virol. 2011;50(4):303–7.PubMedCrossRef
26.
Schlesinger Y, Reich D, Eidelman AI, Schimmel MS, Hassanin J, Miron D. Congenital cytomegalovirus infection in Israel: screening in different subpopulations. Isr Med Assoc J. 2005;7(4):237–40.PubMed
27.
Seror J, Bordes P, Luton D. Dépistage systématique du CMV pendant la grossesse : évaluation des pratiques en Île-de-France. Gynecol Obstet Fertil. 2013;41(10):578–82.PubMedCrossRef
28.
Sousa P, Madureira G, Moucho M, Rouxinol-Dias AL, Montenegro N. Periconceptional CMV infection prevention in Portugal: population subgroup study in a tertiary perinatal care center. J Matern Fetal Neonatal Med. 2018;31(15):1956–61.PubMedCrossRef
29.
Walker SP, Palma-Dias R, Wood EM, Shekleton P, Giles ML. Cytomegalovirus in pregnancy: to screen or not to screen. BMC Pregnancy Childbirth. 2013;13:96.PubMedPubMedCentralCrossRef
30.
Benoist G, Leruez-Ville M, Magny JF, Jacquemard F, Salomon LJ, Ville Y. Management of pregnancies with confirmed cytomegalovirus fetal infection. Fetal Diagn Ther. 2013;33(4):203–14.PubMedCrossRef
31.
Furione M, Rognoni V, Sarasini A, Zavattoni M, Lilleri D, Gerna G, et al. Slow increase in IgG avidity correlates with prevention of human cytomegalovirus transmission to the fetus. J Med Virol. 2013;85(11):1960–7.PubMedCrossRef
32.
Maidji E, Genbacev O, Chang HT, Pereira L. Developmental regulation of human cytomegalovirus receptors in cytotrophoblasts correlates with distinct replication sites in the placenta. J Virol. 2007;81(9):4701–12.PubMedPubMedCentralCrossRef
33.
Public Health England UK. UK standards for microbiology investigations. Cytomegalovirus Serology Virology. 2015;28(3):1–21.
34.
Grangeot-Keros L, Cointe D. Diagnosis and prognostic markers of HCMV infection. J Clin Virol. 2001;21(3):213–21.PubMedCrossRef
35.
Lazzarotto T, Varani S, Spezzacatena P, Gabrielli L, Pradelli P, Guerra B, et al. Maternal IgG avidity and IgM detected by blot as diagnostic tools to identify pregnant women at risk of transmitting cytomegalovirus. Viral Immunol. 2000;13(1):137–41.PubMedCrossRef
36.
Picone O, Grangeot-Keros L, Senat M, Fuchs F, Bouthry E, Ayoubi J, et al. Cytomegalovirus non-primary infection during pregnancy. Can serology help with diagnosis? J Matern Fetal Neonatal Med. 2017;30(2):224–7.PubMedCrossRef
37.
Giannattasio A, Di Costanzo P, De Matteis A, Milite P, De Martino D, Bucci L, et al. Outcomes of congenital cytomegalovirus disease following maternal primary and non-primary infection. J Clin Virol. 2017;96:32–6.PubMedCrossRef
38.
Leruez-Ville M, Magny JF, Couderc S, Pichon C, Parodi M, Bussieres L, et al. Risk factors for congenital Cytomegalovirus infection following primary and nonprimary maternal infection: a prospective neonatal Screening study using polymerase chain reaction in saliva. Clin Infect Dis. 2017;65(3):398–404.PubMedCrossRef
39.
Manicklal S, Emery VC, Lazzarotto T, Boppana SB, Gupta RK. The "silent" global burden of congenital cytomegalovirus. Clin Microbiol Rev. 2013;26(1):86–102.PubMedPubMedCentralCrossRef
40.
Puhakka L, Renko M, Helminen M, Peltola V, Heiskanen-Kosma T, Lappalainen M, et al. Primary versus non-primary maternal cytomegalovirus infection as a cause of symptomatic congenital infection - register-based study from Finland. Infect Dis. 2017;49(6):445–53.CrossRef
41.
Rahav G, Gabbay R, Ornoy A, Shechtman S, Arnon J, Diav-Citrin O. Primary versus nonprimary cytomegalovirus infection during pregnancy, Israel. Emerg Infect Dis. 2007;13(11):1791–3.PubMedPubMedCentralCrossRef
42.
Ross SA, Fowler KB, Ashrith G, Stagno S, Britt WJ, Pass RF, et al. Hearing loss in children with congenital cytomegalovirus infection born to mothers with preexisting immunity. J Pediatr. 2006;148(3):332–6.PubMedCrossRef
43.
Townsend CL, Forsgren M, Ahlfors K, Ivarsson SA, Tookey PA, Peckham CS. Long-term outcomes of congenital cytomegalovirus infection in Sweden and the United Kingdom. Clin Infect Dis. 2013;56(9):1232–9.PubMedPubMedCentralCrossRef
44.
Boppana SB, Rivera LB, Fowler KB, Mach M, Britt WJ. Intrauterine transmission of cytomegalovirus to infants of women with preconceptional immunity. N Engl J Med. 2001;344(18):1366–71.PubMedCrossRef
45.
Nigro G, Mazzocco M, Anceschi MM, La Torre R, Antonelli G, Cosmi EV. Prenatal diagnosis of fetal cytomegalovirus infection after primary or recurrent maternal infection. Obstet Gynecol. 1999;94(6):909–14.PubMed
46.
Ross SA, Arora N, Novak Z, Fowler KB, Britt WJ, Boppana SB. Cytomegalovirus reinfections in healthy seroimmune women. J Infect Dis. 2010;201(3):386–9.PubMedCrossRef
47.
Yamamoto AY, Mussi-Pinhata MM, Boppana SB, Novak Z, Wagatsuma VM, Oliveira Pde F, et al. Human cytomegalovirus reinfection is associated with intrauterine transmission in a highly cytomegalovirus-immune maternal population. Am J OBSTET Gynecol. 2010;202(3):297.e1–8.CrossRef
48.
Conseil supérieur de la santé. La problématique du cytomégalovirus chez la femme enceinte [AVIS DU CONSEIL SUPERIEUR DE LA SANTE N° 9262]. Bruxelles: Conseil supérieur de la santé; 2015.
49.
Yinon Y, Farine D, Yudin MH. Screening, diagnosis, and management of cytomegalovirus infection in pregnancy. Obstet Gynecol Surv. 2010;65(11):736–43.PubMedCrossRef
50.
Haynes RB, Sackett DL, Guyatt GH, Tugwell P. Clinical epidemiology: how to do clinical practice research. Third ed. Philadelphia: Lippincott Williams & Wilkins; 2005. p. 480.
51.
Conseil Supérieur d'Hygiène Publique de France. Avis du Conseil Supérieur d'Hygiène Publique de France. Section des Maladies Transmissibles du 8 mars 2002 relatif aux recommandations pour la prévention de l'infection à cytomégalovirus chez les femmes enceintes. Paris: CSHP; 2002.
52.
Agence nationale d'évaluation en santé. Évaluation de l’intérêt du dépistage de l’infection à cytomégalovirus chez la femme enceinte en France. Paris: ANAES; 2004.
53.
Wilson JMG, Jungner G. The principles and practice of screening for disease. Geneva: World Health Organization; 1968.
54.
Straus S, Richardson WS, Glasziou P, Haynes RB. Evidence-based medicine. How to practice and teach EBM. Edinburgh: Elsevier Churchill Livingstone; 2005. p. 299.
55.
Salmi LR, Coureau G, Bailhache M, Mathoulin-Pélissier S. To screen or not to screen: reconciling individual and population perspectives on screening. Mayo Clin Proc. 2016;91(11):1594–605.PubMedCrossRef
56.
Ministre des solidarités et de la santé. Arrêté du 13 décembre 2018 portant approbation du règlement intérieur du Haut Conseil de la santé publique. J Officiel de la République Française. 2018;2018(294):30.
57.
Moher D, Shamseer L, Clarke M, Ghersi D, Liberati A, Petticrew M, et al. Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement. Syst Rev. 2015;4(1).
58.
Husereau D, Drummond M, Petrou S, Carswell C, Moher D, Greenberg D, et al. Consolidated Health economic evaluation reporting standards (CHEERS) statement. BMJ. 2013;346:f1049.PubMedCrossRef
59.
Drummond MF, Schulpher MJ, Torrance GW, O'Brien BJ, Stoddart GL. Methods for the economic evaluation of health care programmes. 3rd ed. Oxford: Oxford Medical Publications; 2005. p. 182.
60.
Haute Autorité de Santé. Suivi et orientation des femmes enceintes en fonction des situations à risque identifiées. Recommandation de bonne pratique. Saint-Denis: Haute Autorité de Santé; 2016.
61.
Ministre du travail, de l'emploi et de la santé. Arrêté du 23 avril 2012 relatif à l'organisation du dépistage de la surdité permanente néonatale. J Officiel de la République Française. 2012;2012(105):7915.
62.
63.
Revello MG, Tibaldi C, Masuelli G, Frisina V, Sacchi A, Furione M, et al. Prevention of primary Cytomegalovirus infection in pregnancy. EBioMedicine. 2015;2(9):1205–10.PubMedPubMedCentralCrossRef
64.
Vauloup-Fellous C, Picone O, Cordier AG, Parent-du-Chatelet I, Senat MV, Frydman R, et al. Does hygiene counseling have an impact on the rate of CMV primary infection during pregnancy? Results of a 3-year prospective study in a French hospital. J Clin Virol. 2009;46(Suppl 4):S49–53.PubMedCrossRef
65.
66.
Averill LW, Kandula VV, Akyol Y, Epelman M. Fetal brain magnetic resonance imaging findings in congenital Cytomegalovirus infection with postnatal imaging correlation. Semin Ultrasound CT MR. 2015;36(6):476–86.PubMedCrossRef
67.
Bonalumi S, Trapanese A, Santamaria A, D'Emidio L, Mobili L. Cytomegalovirus infection in pregnancy: review of the literature. J Prenat Med. 2011;5(1):1–8.PubMedPubMedCentral
68.
Britt WJ. Congenital Human Cytomegalovirus Infection and the Enigma of Maternal Immunity. J Virol. 2017;91(15):e02392–16.
69.
Britt W. Controversies in the natural history of congenital human cytomegalovirus infection: the paradox of infection and disease in offspring of women with immunity prior to pregnancy. Med Microbiol Immunol. 2015;204(3):263–71.PubMedCrossRef
70.
Cannon MJ, Schmid DS, Hyde TB. Review of cytomegalovirus seroprevalence and demographic characteristics associated with infection. Rev Med Virol. 2010;20(4):202–13.PubMedCrossRef
71.
Cannon MJ, Hyde TB, Schmid DS. Review of cytomegalovirus shedding in bodily fluids and relevance to congenital cytomegalovirus infection. Rev Med Virol. 2011;21(4):240–55.PubMedPubMedCentralCrossRef
72.
Davis NL, King CC, Kourtis AP. Cytomegalovirus infection in pregnancy. Birth Defects Res. 2017;109(5):336–46.PubMedCrossRef
73.
de Vries JJ, van Zwet EW, Dekker FW, Kroes AC, Verkerk PH, Vossen AC. The apparent paradox of maternal seropositivity as a risk factor for congenital cytomegalovirus infection: a population-based prediction model. Rev Med Virol. 2013;23(4):241–9.PubMedCrossRef
74.
75.
Fowler KB, Boppana SB. Congenital cytomegalovirus (CMV) infection and hearing deficit. J Clin Virol. 2006;35(2):226–31.PubMedCrossRef
76.
Hamilton ST, van Zuylen W, Shand A, Scott GM, Naing Z, Hall B, et al. Prevention of congenital cytomegalovirus complications by maternal and neonatal treatments: a systematic review. Rev Med Virol. 2014;24(6):420–33.PubMedCrossRef
77.
Hughes BL, Gyamfi-Bannerman C. Diagnosis and antenatal management of congenital cytomegalovirus infection. Am J Obstet Gynecol. 2016;214(6):B5–b11.PubMedCrossRef
78.
Hyde TB, Schmid DS, Cannon MJ. Cytomegalovirus seroconversion rates and risk factors: implications for congenital CMV. Rev Med Virol. 2010;20(5):311–26.PubMedCrossRef
79.
80.
Jarvis D, Mooney C, Cohen J, Papaioannou D, Bradburn M, Sutton A, et al. A systematic review and meta-analysis to determine the contribution of mr imaging to the diagnosis of foetal brain abnormalities in utero. Eur Radiol. 2017;27(6):2367–80.PubMedCrossRef
81.
Luck SE, Wieringa JW, Blazquez-Gamero D, Henneke P, Schuster K, Butler K, et al. Congenital Cytomegalovirus: a European expert consensus statement on diagnosis and management. Pediatr Infect Dis J. 2017;36(12):1205–13.PubMedCrossRef
82.
Malm G, Engman ML. Congenital cytomegalovirus infections. Semin Fetal Neonatal Med. 2007;12(3):154–9.PubMedCrossRef
83.
Marsico C, Kimberlin DW. Congenital Cytomegalovirus infection: advances and challenges in diagnosis, prevention and treatment. Ital J Pediatr. 2017;43(1):38.PubMedPubMedCentralCrossRef
84.
McCarthy FP, Giles ML, Rowlands S, Purcell KJ, Jones CA. Antenatal interventions for preventing the transmission of cytomegalovirus (CMV) from the mother to fetus during pregnancy and adverse outcomes in the congenitally infected infant. Cochrane Database Syst Rev. 2011;16(3):Cd008371.
85.
Peckham C, Tookey P, Logan S, Giaquinto C. Screening options for prevention of congenital cytomegalovirus infection. J Med Screen. 2001;8(3):119–24.PubMedCrossRef
86.
Rawlinson WD, Hamilton ST, van Zuylen WJ. Update on treatment of cytomegalovirus infection in pregnancy and of the newborn with congenital cytomegalovirus. Curr Opin Infect Dis. 2016;29(6):615–24.PubMedCrossRef
87.
Revello MG, Gerna G. Pathogenesis and prenatal diagnosis of human cytomegalovirus infection. J Clin Virol. 2004;29(2):71–83.PubMedCrossRef
88.
Revello MG, Zavattoni M, Furione M, Lilleri D, Gorini G, Gerna G. Diagnosis and outcome of preconceptional and periconceptional primary human cytomegalovirus infections. J Infect Dis. 2002;186(4):553–7.PubMedCrossRef
89.
Revello MG, Gerna G. Diagnosis and management of human cytomegalovirus infection in the mother, fetus, and newborn infant. Clin Microbiol Rev. 2002;15(4):680–715.PubMedPubMedCentralCrossRef
90.
Ross DS, Dollard SC, Victor M, Sumartojo E, Cannon MJ. The epidemiology and prevention of congenital cytomegalovirus infection and disease: activities of the Centers for Disease Control and Prevention Workgroup. J Womens Health. 2006;15(3):224–9.CrossRef
91.
92.
Smit GSA, Padalko E, Van Acker J, Hens N, Dorny P, Speybroeck N, et al. Public Health impact of congenital toxoplasmosis and Cytomegalovirus infection in Belgium, 2013: a systematic review and data synthesis. Clin Infect Dis. 2017;65(4):661–8.PubMedCrossRef
93.
Stagno S, Cloud GA. Working parents: the impact of day care and breast-feeding on cytomegalovirus infections in offspring. Proc Natl Acad Sci U S A. 1994;91(7):2384–9.PubMedPubMedCentralCrossRef
94.
Teissier N, Bernard S, Quesnel S, Van Den Abbeele T. Audiovestibular consequences of congenital cytomegalovirus infection. Eur Ann Otorhinolaryngol Head Neck Dis. 2016;133(6):413–8.PubMedCrossRef
95.
van Zuylen WJ, Hamilton ST, Naing Z, Hall B, Shand A, Rawlinson WD. Congenital cytomegalovirus infection: clinical presentation, epidemiology, diagnosis and prevention. Obstet Med. 2014;7(4):140–6.PubMedPubMedCentralCrossRef
96.
Wang C, Zhang X, Bialek S, Cannon MJ. Attribution of congenital cytomegalovirus infection to primary versus non-primary maternal infection. Clin Infect Dis. 2011;52(2):e11–3.PubMedCrossRef
97.
Antona D, Lepoutre A, Fonteneau L, Baudon C, Halftermeyer-Zhou F. Y LES, et al. Seroprevalence of cytomegalovirus infection in France in 2010. Epidemiol Infect. 2017;145(7):1471–8.PubMedCrossRef
98.
Picone O, Vauloup-Fellous C, Cordier AG, Guitton S, Senat MV, Fuchs F, et al. A series of 238 cytomegalovirus primary infections during pregnancy: description and outcome. Prenat Diagn. 2013;33(8):751–8.PubMedCrossRef
99.
Enders G, Bader U, Lindemann L, Schalasta G, Daiminger A. Prenatal diagnosis of congenital cytomegalovirus infection in 189 pregnancies with known outcome. Prenat Diagn. 2001;21(5):362–77.PubMedCrossRef
100.
Gouarin S, Gault E, Vabret A, Cointe D, Rozenberg F, Grangeot-Keros L, et al. Real-time PCR quantification of human cytomegalovirus DNA in amniotic fluid samples from mothers with primary infection. J Clin Microbiol. 2002;40(5):1767–72.PubMedPubMedCentralCrossRef
101.
Enders G, Daiminger A, Bader U, Exler S, Enders M. Intrauterine transmission and clinical outcome of 248 pregnancies with primary cytomegalovirus infection in relation to gestational age. J Clin Virol. 2011;52(3):244–6.PubMedCrossRef
102.
Ahlfors K, Ivarsson SA, Harris S. Report on a long-term study of maternal and congenital cytomegalovirus infection in Sweden. Review of prospective studies available in the literature. Scand J Infect Dis. 1999;31(5):443–57.PubMedCrossRef
103.
Leruez-Ville M, Stirnemann J, Sellier Y, Guilleminot T, Dejean A, Magny JF, et al. Feasibility of predicting the outcome of fetal infection with cytomegalovirus at the time of prenatal diagnosis. Am J Obstet Gynecol. 2016;215(3):342.e1–9.CrossRef
104.
Townsend CL, Peckham CS, Tookey PA. Surveillance of congenital cytomegalovirus in the UK and Ireland. Arch Dis Child Fetal Neonatal Ed. 2011;96(6):F398–403.PubMedCrossRef
105.
Dreher AM, Arora N, Fowler KB, Novak Z, Britt WJ, Boppana SB, et al. Spectrum of disease and outcome in children with symptomatic congenital cytomegalovirus infection. J Pediatr. 2014;164(4):855–9.PubMedPubMedCentralCrossRef
106.
Fowler KB, Stagno S, Pass RF, Britt WJ, Boll TJ, Alford CA. The outcome of congenital cytomegalovirus infection in relation to maternal antibody status. N Engl J Med. 1992;326(10):663–7.PubMedCrossRef
107.
Leruez-Ville M, Ghout I, Bussieres L, Stirnemann J, Magny JF, Couderc S, et al. In utero treatment of congenital cytomegalovirus infection with valacyclovir in a multicenter, open-label, phase II study. Am J Obstet Gynecol. 2016;215(4):462.e1–e10.CrossRef
108.
Lipitz S, Yinon Y, Malinger G, Yagel S, Levit L, Hoffman C, et al. Risk of cytomegalovirus-associated sequelae in relation to time of infection and findings on prenatal imaging. Ultrasound Obstet Gynecol. 2013;41(5):508–14.PubMedCrossRef
109.
Leruez-Ville M, Sellier Y, Salomon LJ, Stirnemann JJ, Jacquemard F, Ville Y. Prediction of fetal infection in cases with cytomegalovirus immunoglobulin M in the first trimester of pregnancy: a retrospective cohort. Clin Infect Dis. 2013;56(10):1428–35.PubMedCrossRef
110.
Beloosesky R, Feldblum I, Shrim A, Kertes J, Segal J, Bachar R, et al. Trends in continuity of pregnancy in women with positive Cytomegalovirus IgM during the first trimester, 2008-2009. Isr Med Assoc J. 2017;19(8):484–8.PubMed
111.
Iwasenko JM, Howard J, Arbuckle S, Graf N, Hall B, Craig ME, et al. Human cytomegalovirus infection is detected frequently in stillbirths and is associated with fetal thrombotic vasculopathy. J Infect Dis. 2011;203(11):1526–33.PubMedCrossRef
112.
Parent du Châtelet I, Grangeot-Keros L, Le Strat Y, Leblond A, Six C, Lévy-Bruhl D. Enquête sur les infections maternofoetales à cytomégalovirus détectées pendant la grossesse ou à la naissance en France métropolitaine, novembre 2004-janvier 2005. Bull Epidémiol Hebdomadaire. 2008;2008(14–15):124–8.
113.
EURO-PERISTAT. European Perinatal Health Report. The health and care of pregnant women and babies in Europe in 2010. Bruxelles: EURO-PERISTAT; 2013.
114.
Benachi A, Picone O, Dumez Y. CMV infection: when should medical termination of pregnancy be discussed? Gynecol Obstet Fertil. 2003;31(6):521–4.PubMedCrossRef
115.
116.
Delay F, Coste Burel M, Joubert M, Winer N. [Cytomegalovirus infection in pregnancy: a fourteen-year review in a pluridisciplinary prenatal center]. J Gynecol Obstet. Biol Reprod. 2016;45(9):1115–26.
117.
Direction des études, de l'évaluation et des statistiques. 211900 interruptions volontaires de grossesse en 2016. Paris: Ministère des solidarités; 2017.
118.
Goffinet F. CMV infection: when should medical termination of pregnancy be discussed? A. Benachi. Gynecol Obstet Fertil. 2003;31(11):993–4.PubMedCrossRef
119.
Ludwig A, Hengel H. Epidemiological impact and disease burden of congenital cytomegalovirus infection in Europe. Euro Surveill. 2009;14(9):26–32.PubMed
120.
Williams EJ, Embleton ND, Clark JE, Bythell M, Ward Platt MP, Berrington JE. Viral infections: contributions to late fetal death, stillbirth, and infant death. J Pediatr. 2013;163(2):424–8.PubMedCrossRef
121.
Griffiths PD, Baboonian C, Rutter D, Peckham C. Congenital and maternal cytomegalovirus infections in a London population. Br J Obstet Gynaecol. 1991;98(2):135–40.PubMedCrossRef
122.
National Screening Committee UK. Newborn screening for cytomeglovirus. External review against programme appraisal criteria for the UK National Screening Committee. London: Public Health England; 2017.
123.
Boppana SB, Fowler KB. Insight Into Long-term Neurodevelopmental Outcomes in Asymptomatic Congenital CMV Infection. Pediatrics. 2017;140(5):e20172526.
124.
Pass RF, Fowler KB, Boppana SB, Britt WJ, Stagno S. Congenital cytomegalovirus infection following first trimester maternal infection: symptoms at birth and outcome. J Clin Virol. 2006;35(2):216–20.PubMedCrossRef
125.
126.
Kotton CN, Kumar D, Caliendo AM, Asberg A, Chou S, Danziger-Isakov L, et al. Updated international consensus guidelines on the management of cytomegalovirus in solid-organ transplantation. Transplantation. 2013;96(4):333–60.PubMedCrossRef
127.
Seed CR, Piscitelli LM, Maine GT, Lazzarotto T, Doherty K, Stricker R, et al. Validation of an automated immunoglobulin G-only cytomegalovirus (CMV) antibody screening assay and an assessment of the risk of transfusion transmitted CMV from seronegative blood. Transfusion. 2009;49(1):134–45.PubMedCrossRef
128.
Weber B, Fall EM, Berger A, Doerr HW. Screening of blood donors for human cytomegalovirus (HCMV) IgG antibody with an enzyme immunoassay using recombinant antigens. J Clin Virol. 1999;14(3):173–81.PubMedCrossRef
129.
Genser B, Truschnig-Wilders M, Stunzner D, Landini MP, Halwachs-Baumann G. Evaluation of five commercial enzyme immunoassays for the detection of human cytomegalovirus-specific IgM antibodies in the absence of a commercially available gold standard. Clin Chem Lab Med. 2001;39(1):62–70.PubMedCrossRef
130.
Prince HE, Lape-Nixon M. Role of cytomegalovirus (CMV) IgG avidity testing in diagnosing primary CMV infection during pregnancy. Clin Vaccine Immunol. 2014;21(10):1377–84.PubMedPubMedCentralCrossRef
131.
Revello MG, Vauloup-Fellous C, Grangeot-Keros L, van Helden J, Dickstein Y, Lipkin I, et al. Clinical evaluation of new automated cytomegalovirus IgM and IgG assays for the Elecsys((R)) analyser platform. Eur J Clin Microbiol INFECT Dis. 2012;31(12):3331–9.PubMedCrossRef
132.
Weber B, Prosser F, Munkwitz A, Doerr HW. Serological diagnosis of cytomegalovirus infection: comparison of 8 enzyme immunoassays for the detection of HCMV-specific IgM antibody. Clin Diagn Virol. 1994;2(4–5):245–59.PubMedCrossRef
133.
Bodeus M, Beulne D, Goubau P. Ability of three IgG-avidity assays to exclude recent cytomegalovirus infection. Eur J Clinical Microbiol Infect Dis. 2001;20(4):248–52.
134.
Delforge ML, Desomberg L, Montesinos I. Evaluation of the new LIAISON((R)) CMV IgG, IgM and IgG avidity II assays. J Clin Virol. 2015;72:42–5.PubMedCrossRef
135.
Grangeot-Keros L, Mayaux MJ, Lebon P, Freymuth F, Eugene G, Stricker R, et al. Value of cytomegalovirus (CMV) IgG avidity index for the diagnosis of primary CMV infection in pregnant women. J Infect Dis. 1997;175(4):944–6.PubMedCrossRef
136.
Guisasola ME, Ramos B, Sanz JC, Garcia-Bermejo I, De Ory Manchon F. Comparison of IgG avidity assays in the confirmation of the diagnosis of cytomegalovirus primary infection. APMIS. 2010;118(12):991–3.PubMedCrossRef
137.
Lagrou K, Bodeus M, Van Ranst M, Goubau P. Evaluation of the new architect cytomegalovirus immunoglobulin M (IgM), IgG, and IgG avidity assays. J Clin Microbiol. 2009;47(6):1695–9.PubMedPubMedCentralCrossRef
138.
Lazzarotto T, Brojanac S, Maine GT, Landini MP. Search for cytomegalovirus-specific immunoglobulin M: comparison between a new western blot, conventional western blot, and nine commercially available assays. Clin Diagn Lab Immunol. 1997;4(4):483–6.PubMedPubMedCentralCrossRef
139.
Lazzarotto T, Spezzacatena P, Varani S, Gabrielli L, Pradelli P, Guerra B, et al. Anticytomegalovirus (anti-CMV) immunoglobulin G avidity in identification of pregnant women at risk of transmitting congenital CMV infection. Clin Diagn Lab Immunol. 1999;6(1):127–9.PubMedPubMedCentralCrossRef
140.
Revello MG, Genini E, Gorini G, Klersy C, Piralla A, Gerna G. Comparative evaluation of eight commercial human cytomegalovirus IgG avidity assays. J Clin Virol. 2010;48(4):255–9.PubMedCrossRef
141.
Vauloup-Fellous C, Berth M, Heskia F, Dugua JM, Grangeot-Keros L. Re-evaluation of the VIDAS((R)) cytomegalovirus (CMV) IgG avidity assay: determination of new cut-off values based on the study of kinetics of CMV-IgG maturation. J Clin Virol. 2013;56(2):118–23.PubMedCrossRef
142.
Vauloup-Fellous C, Lazzarotto T, Revello MG, Grangeot-Keros L. Clinical evaluation of the Roche Elecsys CMV IgG avidity assay. Eur J Clin Microbiol Infect Dis. 2014;33(8):1365–9.PubMedPubMedCentralCrossRef
143.
Revello MG, Gorini G, Gerna G. Clinical evaluation of a chemiluminescence immunoassay for determination of immunoglobulin g avidity to human cytomegalovirus. Clin Diagn Lab Immunol. 2004;11(4):801–5.PubMedCrossRef
144.
Yamamoto AY, Castellucci RA, Aragon DC, Mussi-Pinhata MM. Early high CMV seroprevalence in pregnant women from a population with a high rate of congenital infection. Epidemiol Infect. 2013;141(10):2187–91.PubMedCrossRef
145.
Yamamoto AY, Mussi-Pinhata MM, Isaac Mde L, Amaral FR, Carvalheiro CG, Aragon DC, et al. Congenital cytomegalovirus infection as a cause of sensorineural hearing loss in a highly immune population. Pediatr Infect Dis J. 2011;30(12):1043–6.PubMedPubMedCentralCrossRef
146.
Munro SC, Trincado D, Hall B, Rawlinson WD. Symptomatic infant characteristics of congenital cytomegalovirus disease in Australia. J Paediatr Child Health. 2005;41(8):449–52.PubMedCrossRef
147.
Benoist G, Salomon LJ, Mohlo M, Suarez B, Jacquemard F, Ville Y. Cytomegalovirus-related fetal brain lesions: comparison between targeted ultrasound examination and magnetic resonance imaging. Ultrasound Obstet Gynecol. 2008;32(7):900–5.PubMedCrossRef
148.
Fabbri E, Revello MG, Furione M, Zavattoni M, Lilleri D, Tassis B, et al. Prognostic markers of symptomatic congenital human cytomegalovirus infection in fetal blood. Bjog. 2011;118(4):448–56.PubMedCrossRef
149.
Faure-Bardon V, Millischer AE, Deloison B, Sonigo P, Grevent D, Salomon L, et al. Refining the prognosis of fetuses infected with Cytomegalovirus in the first trimester of pregnancy by serial prenatal assessment: a single-Centre retrospective study. BJOG. 2020;127(3):355–62.
150.
Coleman JL, Steele RW. Preventing congenital Cytomegalovirus infection. Clin Pediatr (Phila). 2017;56(12):1085–94.CrossRef
151.
Bilavsky E, Pardo J, Attias J, Levy I, Magny JF, Ville Y, et al. Clinical implications for children born with congenital Cytomegalovirus infection following a negative amniocentesis. Clin Infect Dis. 2016;63(1):33–8.PubMedCrossRef
152.
Adler SP, Finney JW, Manganello AM, Best AM. Prevention of child-to-mother transmission of cytomegalovirus by changing behaviors: a randomized controlled trial. Pediatr Infect Dis J. 1996;15(3):240–6.PubMedCrossRef
153.
Avettand-Fenoel V, Marlin S, Vauloup-Fellous C, Loundon N, Francois M, Couloigner V, et al. Congenital cytomegalovirus is the second most frequent cause of bilateral hearing loss in young French children. J Pediatr. 2013;162(3):593–9.PubMedCrossRef
154.
Benoist G, Salomon LJ, Jacquemard F, Daffos F, Ville Y. The prognostic value of ultrasound abnormalities and biological parameters in blood of fetuses infected with cytomegalovirus. Bjog. 2008;115(7):823–9.PubMedCrossRef
155.
Carrara J, Delaveaucoupet J, Cordier AG, Vauloup-Fellous C, Senat MV, Ayoubi JM, et al. Detailed in utero ultrasound description of 34 cases of congenital cytomegalovirus infection. J Gynecol Obstet Biol Reprod. 2016;45(4):397–406.CrossRef
156.
Cheeran MC, Lokensgard JR, Schleiss MR. Neuropathogenesis of congenital cytomegalovirus infection: disease mechanisms and prospects for intervention. Clin Microbiol Rev. 2009;22(1):99–126 Table of Contents.PubMedPubMedCentralCrossRef
157.
Daiminger A, Bader U, Enders G. Pre- and periconceptional primary cytomegalovirus infection: risk of vertical transmission and congenital disease. Bjog. 2005;112(2):166–72.PubMedCrossRef
158.
Farkas N, Hoffmann C, Ben-Sira L, Lev D, Schweiger A, Kidron D, et al. Does normal fetal brain ultrasound predict normal neurodevelopmental outcome in congenital cytomegalovirus infection? Prenat Diagn. 2011;31(4):360–6.PubMedCrossRef
159.
Lanari M, Capretti MG, Lazzarotto T, Gabrielli L, Rizzollo S, Mostert M, et al. Neuroimaging in CMV congenital infected neonates: how and when. Early Hum Dev. 2012;88(Suppl 2):S3–5.PubMedCrossRef
160.
Lipitz S, Hoffmann C, Feldman B, Tepperberg-Dikawa M, Schiff E, Weisz B. Value of prenatal ultrasound and magnetic resonance imaging in assessment of congenital primary cytomegalovirus infection. Ultrasound Obstet Gynecol. 2010;36(6):709–17.PubMedCrossRef
161.
Rolland M, Li X, Sellier Y, Martin H, Perez-Berezo T, Rauwel B, et al. PPARgamma is activated during congenital Cytomegalovirus infection and inhibits Neuronogenesis from human neural stem cells. PLoS Pathog. 2016;12(4):e1005547.PubMedPubMedCentralCrossRef
162.
Gandhi RS, Fernandez-Alvarez JR, Rabe H. Management of congenital cytomegalovirus infection: an evidence-based approach. Acta Paediatr. 2010;99(4):509–15.PubMedCrossRef
163.
Leyder M, Vorsselmans A, Done E, Van Berkel K, Faron G, Foulon I, et al. Primary maternal cytomegalovirus infections: accuracy of fetal ultrasound for predicting sequelae in offspring. Am J Obstet Gynecol. 2016;215(5):638.e1–8.CrossRef
164.
Picone O, Mandelbrot L. Primary maternal cytomegalovirus infections: accuracy of fetal ultrasound to predict sequelae in offspring. Am J Obstet Gynecol. 2017;216(3):329–30.PubMedCrossRef
165.
Ross SA, Ahmed A, Palmer AL, Michaels MG, Sanchez PJ, Stewart A, et al. Newborn Dried Blood Spot Polymerase Chain Reaction to Identify Infants with Congenital Cytomegalovirus-Associated Sensorineural Hearing Loss. J Pediatr. 2017;184:57–61.e1.PubMedPubMedCentralCrossRef
166.
Gaytant MA, Galama JM, Semmekrot BA, Melchers WJ, Sporken JM, Oosterbaan HP, et al. The incidence of congenital cytomegalovirus infections in the Netherlands. J Med Virol. 2005;76(1):71–5.PubMedCrossRef
167.
Fowler KB, McCollister FP, Dahle AJ, Boppana S, Britt WJ, Pass RF. Progressive and fluctuating sensorineural hearing loss in children with asymptomatic congenital cytomegalovirus infection. J Pediatr. 1997;130(4):624–30.PubMedCrossRef
168.
de Villemeur AB, Gratacap-Cavallier B, Casey R, Baccard-Longere M, Goirand L, Seigneurin JM, et al. Occupational risk for cytomegalovirus, but not for parvovirus B19 in child-care personnel in France. J Inf Secur. 2011;63(6):457–67.
169.
Joseph SA, Beliveau C, Muecke CJ, Rahme E, Soto JC, Flowerdew G, et al. Risk factors for cytomegalovirus seropositivity in a population of day care educators in Montreal, Canada. Occup Med (Lond). 2005;55(7):564–7.CrossRef
170.
Lepage N, Leroyer A, Cherot-Kornobis N, Lartigau I, Miczek S, Sobaszek A. Cytomegalovirus seroprevalence in exposed and unexposed populations of hospital employees. Eur J Clin Microbiol Infect Dis. 2011;30(1):65–70.PubMedCrossRef
171.
Stelma FF, Smismans A, Goossens VJ, Bruggeman CA, Hoebe CJ. Occupational risk of human Cytomegalovirus and parvovirus B19 infection in female day care personnel in the Netherlands; a study based on seroprevalence. Eur J Clin Microbiol Infect Dis. 2009;28(4):393–7.PubMedCrossRef
172.
Balcarek KB, Bagley R, Cloud GA, Pass RF. Cytomegalovirus infection among employees of a children's hospital. No evidence for increased risk associated with patient care. Jama. 1990;263(6):840–4.PubMedCrossRef
173.
Balfour CL, Balfour HH Jr. Cytomegalovirus is not an occupational risk for nurses in renal transplant and neonatal units. Results of a prospective surveillance study. Jama. 1986;256(14):1909–14.PubMedCrossRef
174.
Dworsky ME, Welch K, Cassady G, Stagno S. Occupational risk for primary cytomegalovirus infection among pediatric health-care workers. N Engl J Med. 1983;309(16):950–3.PubMedCrossRef
175.
Hatherley LI. Is primary cytomegalovirus infection an occupational hazard for obstetric nurses? A serological study. Infect Control. 1986;7(9):452–5.PubMedCrossRef
176.
Lipscomb JA, Linnemann CC Jr, Hurst PF, Myers MG, Stringer W, Moore P, et al. Prevalence of cytomegalovirus antibody in nursing personnel. Infect Control. 1984;5(11):513–8.PubMedCrossRef
177.
Sobaszek A, Fantoni-Quinton S, Frimat P, Leroyer A, Laynat A, Edme JL. Prevalence of cytomegalovirus infection among health care workers in pediatric and immunosuppressed adult units. J Occup Environ Med. 2000;42(11):1109–14.PubMedCrossRef
178.
Adler SP, Finney JW, Manganello AM, Best AM. Prevention of child-to-mother transmission of cytomegalovirus among pregnant women. J Pediatr. 2004;145(4):485–91.PubMedCrossRef
179.
Pass RF, Anderson B. Mother-to-child transmission of Cytomegalovirus and prevention of congenital infection. J Pediatric Infect Dis Soc. 2014;3(Suppl 1):S2–6.PubMedPubMedCentralCrossRef
180.
Knowledge and practices of obstetricians and gynecologists regarding cytomegalovirus infection during pregnancy--United States, 2007. MMWR Morb Mortal Wkly Rep. 2008;57(3):65–8.
181.
Cannon MJ, Westbrook K, Levis D, Schleiss MR, Thackeray R, Pass RF. Awareness of and behaviors related to child-to-mother transmission of cytomegalovirus. Prev Med. 2012;54(5):351–7.PubMedPubMedCentralCrossRef
182.
Price SM, Bonilla E, Zador P, Levis DM, Kilgo CL, Cannon MJ. Educating women about congenital cytomegalovirus: assessment of health education materials through a web-based survey. BMC Womens Health. 2014;14:144.PubMedPubMedCentralCrossRef
183.
Binda S, Pellegrinelli L, Terraneo M, Caserini A, Primache V, Bubba L, et al. What people know about congenital CMV: an analysis of a large heterogeneous population through a web-based survey. BMC Infect Dis. 2016;16(1):513.PubMedPubMedCentralCrossRef
184.
Cordier AG, Guitton S, Vauloup-Fellous C, Grangeot-Keros L, Ayoubi JM, Benachi A, et al. Awareness of cytomegalovirus infection among pregnant women in France. J Clin Virol. 2012;53(4):332–7.PubMedCrossRef
185.
Jeon J, Victor M, Adler SP, Arwady A, Demmler G, Fowler K, et al. Knowledge and awareness of congenital cytomegalovirus among women. Infect Dis Obstet Gynecol. 2006;2006:80383.PubMedPubMedCentralCrossRef
186.
Mazzitelli M, Micieli M, Votino C, Visconti F, Quaresima P, Strazzulla A, et al. Knowledge of human Cytomegalovirus infection and prevention in pregnant women: a baseline, Operational Survey. Infect Dis Obstet Gynecol. 2017;2017:5495927.PubMedPubMedCentralCrossRef
187.
Pereboom MT, Mannien J, Spelten ER, Schellevis FG, Hutton EK. Observational study to assess pregnant women's knowledge and behaviour to prevent toxoplasmosis, listeriosis and cytomegalovirus. BMC Pregnancy Childbirth. 2013;13:98.PubMedPubMedCentralCrossRef
188.
Willame A, Blanchard-Rohner G, Combescure C, Irion O, Posfay-Barbe K. Martinez de Tejada B. awareness of Cytomegalovirus infection among pregnant women in Geneva, Switzerland: a cross-sectional study. Int J Environ Res Public Health. 2015;12(12):15285–97.PubMedPubMedCentralCrossRef
189.
Wizman S, Lamarre V, Coic L, Kakkar F, Le Meur JB, Rousseau C, et al. Awareness of cytomegalovirus and risk factors for susceptibility among pregnant women, in Montreal, Canada. BMC Pregnancy Childbirth. 2016;16:54.PubMedPubMedCentralCrossRef
190.
Cordier AG, Guitton S, Vauloup-Fellous C, Grangeot-Keros L, Benachi A, Picone O. Awareness and knowledge of congenital cytomegalovirus infection among health care providers in France. J Clin Virol. 2012;55(2):158–63.PubMedCrossRef
191.
Shand AW, Luk W, Nassar N, Hui L, Dyer K, Rawlinson W. Cytomegalovirus (CMV) infection and pregnancy-potential for improvements in Australasian maternity health providers' knowledge. J Matern Fetal Neonatal Med. 2018;31(19):2515–20.PubMedCrossRef
192.
von Gartzen A, Hollins Martin CJ. An email survey of midwives knowledge about CytoMegaloVirus (CMV) in Hannover and a skeletal framework for a proposed teaching program. Nurse Educ Pract. 2013;13(5):481–6.CrossRef
Metadata
Title
Hygiene promotion might be better than serological screening to deal with Cytomegalovirus infection during pregnancy: a methodological appraisal and decision analysis
Authors
Agathe Billette de Villemeur
Pierre Tattevin
Louis-Rachid Salmi
the French Haut Conseil de la santé publique Working Group
Publication date
01-12-2020
Publisher
BioMed Central
Published in
BMC Infectious Diseases / Issue 1/2020
Electronic ISSN: 1471-2334
DOI
https://doi.org/10.1186/s12879-020-05139-8

Other articles of this Issue 1/2020

BMC Infectious Diseases 1/2020 Go to the issue

Research article

The risk factors of intracranial infection in patients with intracerebral hemorrhage undergone hematoma puncture: what should we care

Research article

Disease burden and prognostic factors for clinical failure in elderly community acquired pneumonia patients

Research article

Performance of malaria microscopy external quality assessment and networking among health facilities in west Amhara region, Ethiopia

Research article

A comparative genomic analysis between methicillin-resistant Staphylococcus aureus strains of hospital acquired and community infections in Yunnan province of China

Editorial

Potential implications of SARS-CoV-2 epidemic in Africa: where are we going from now?

Research article

Zoonotic transmission of Teladorsagia circumcincta and Trichostrongylus species in Guilan province, northern Iran: molecular and morphological characterizations

ACC 2024 Congress Coverage

Heart Failure Video

Year in Review: Heart failure and cardiomyopathies

Watch now

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits